It has been almost exactly a month since the CanG came into force in Germany, legalizing adult consumption and possession within strict limits.
While the law's passage was hailed as a milestone for cannabis reform in Europe, cannabis advocates and businesses have expressed disappointment that the law's original goals of creating a commercial market for adult use were overturned during the legislative process.
However, with the removal of cannabis from the narcotic list, a new, not unexpected, “medical-recreational” market is beginning to emerge, with many new patients using the now simple and cost-effective route of telemedicine to obtain cannabis.
Insurance companies and pharmacies are now fighting this phenomenon and there is speculation that reimbursement for cannabis flowers could soon become much more difficult.
